This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
SB70-SSA2-SA4,91,55 632.7495 (4) (b) The coverage has a term of not more than 12 3 months.
SB70-SSA2-SA4,99 6Section 99. 632.7495 (4) (c) of the statutes is amended to read:
SB70-SSA2-SA4,91,117 632.7495 (4) (c) The coverage term aggregated with all consecutive periods of
8the insurer's coverage of the insured by individual health benefit plan coverage not
9required to be renewed under this subsection does not exceed 18 6 months. For
10purposes of this paragraph, coverage periods are consecutive if there are no more
11than 63 days between the coverage periods.
SB70-SSA2-SA4,100 12Section 100. 632.7496 of the statutes is created to read:
SB70-SSA2-SA4,91,15 13632.7496 Coverage requirements for short-term plans. (1) Definition.
14In this section, “short-term, limited duration plan” means an individual health
15benefit plan described in s. 632.7495 (4).
SB70-SSA2-SA4,91,18 16(2) Guaranteed issue. An insurer that offers a short-term, limited duration
17plan shall accept every individual in this state who applies for coverage regardless
18of whether the individual has a preexisting condition.
SB70-SSA2-SA4,91,24 19(3) Prohibiting discrimination based on health status. (a) An insurer that
20offers a short-term, limited duration plan may not establish rules for the eligibility
21of any individual to enroll, or for the continued eligibility of any individual to remain
22enrolled, under a short-term, limited duration plan based on any of the following
23health status-related factors with respect to the individual or a dependent of the
24individual:
SB70-SSA2-SA4,91,2525 1. Health status.
SB70-SSA2-SA4,92,1
12. Medical condition, including both physical and mental illnesses.
SB70-SSA2-SA4,92,22 3. Claims experience.
SB70-SSA2-SA4,92,33 4. Receipt of health care.
SB70-SSA2-SA4,92,44 5. Medical history.
SB70-SSA2-SA4,92,55 6. Genetic information.
SB70-SSA2-SA4,92,76 7. Evidence of insurability, including conditions arising out of acts of domestic
7violence.
SB70-SSA2-SA4,92,88 8. Disability.
SB70-SSA2-SA4,92,169 (b) An insurer that offers a short-term, limited duration plan may not require
10any individual, as a condition of enrollment or continued enrollment under the
11short-term, limited duration plan, to pay, on the basis of any health status-related
12factor described under par. (a) with respect to the individual or a dependent of the
13individual, a premium or contribution or a deductible, copayment, or coinsurance
14amount that is greater than the premium or contribution or deductible, copayment,
15or coinsurance amount respectively for a similarly situated individual enrolled
16under the short-term, limited duration plan.
SB70-SSA2-SA4,92,19 17(4) Premium rate variation. An insurer that offers a short-term, limited
18duration plan may vary premium rates for a specific short-term, limited duration
19plan based only on the following considerations:
SB70-SSA2-SA4,92,2120 (a) Whether the short-term, limited duration plan covers an individual or a
21family.
SB70-SSA2-SA4,92,2222 (b) Rating area in the state, as established by the commissioner.
SB70-SSA2-SA4,92,2523 (c) Age, except that the rate may not vary by more than 3 to 1 for adults over
24the age groups and the age bands shall be consistent with recommendations of the
25National Association of Insurance Commissioners.
SB70-SSA2-SA4,93,1
1(d) Tobacco use, except that the rate may not vary by more than 1.5 to 1.
SB70-SSA2-SA4,93,3 2(5) Annual and lifetime limits. A short-term, limited duration plan may not
3establish any of the following:
SB70-SSA2-SA4,93,54 (a) Lifetime limits on the dollar value of benefits for an enrollee or a dependent
5of an enrollee under the short-term, limited duration plan.
SB70-SSA2-SA4,93,86 (b) Limits on the dollar value of benefits for an enrollee or a dependent of an
7enrollee under the short-term, limited duration plan for a term of coverage or for the
8aggregate duration of the short-term, limited duration plan.
SB70-SSA2-SA4,101 9Section 101. 632.76 (2) (ac) 3. (intro.) of the statutes is amended to read:
SB70-SSA2-SA4,93,1210 632.76 (2) (ac) 3. (intro.) Except as the commissioner provides by rule under
11s. 632.7495 (5), all of the following apply to an individual disability insurance policy
12that is a short-term policy, limited duration plan subject to s. 632.7495 (4) and (5):
SB70-SSA2-SA4,102 13Section 102. 632.76 (2) (ac) 3. b. of the statutes is amended to read:
SB70-SSA2-SA4,93,1914 632.76 (2) (ac) 3. b. The policy shall reduce the length of time during which a
15may not impose any preexisting condition exclusion may be imposed by the
16aggregate of the insured's consecutive periods of coverage under the insurer's
17individual disability insurance policies that are short-term policies subject to s.
18632.7495 (4) and (5). For purposes of this subd. 3. b., coverage periods are consecutive
19if there are no more than 63 days between the coverage periods
.
SB70-SSA2-SA4,103 20Section 103. 632.862 of the statutes is created to read:
SB70-SSA2-SA4,93,22 21632.862 Application of prescription drug payments. (1) Definitions. In
22this section:
SB70-SSA2-SA4,93,2323 (a) “Brand name” has the meaning given in s. 450.12 (1) (a).
SB70-SSA2-SA4,93,2424 (b) “Brand name drug” means any of the following:
SB70-SSA2-SA4,94,2
11. A prescription drug that contains a brand name and that has no generic
2equivalent.
SB70-SSA2-SA4,94,73 2. A prescription drug that contains a brand name and has a generic equivalent
4but for which the enrollee has received prior authorization from the insurer offering
5the disability insurance policy or self-insured health plan or authorization from a
6physician to obtain the prescription drug under the disability insurance policy or
7self-insured health plan.
SB70-SSA2-SA4,94,88 (c) “Disability insurance policy” has the meaning given in s. 632.895 (1) (a).
SB70-SSA2-SA4,94,99 (d) “Prescription drug” has the meaning given in s. 450.01 (20).
SB70-SSA2-SA4,94,1110 (e) “Self-insured health plan” means a self-insured health plan of the state or
11a county, city, village, town, or school district.
SB70-SSA2-SA4,94,17 12(2) Application of discounts. A disability insurance policy that offers a
13prescription drug benefit or a self-insured health plan shall apply to any calculation
14of an out-of-pocket maximum amount and to any deductible of the disability
15insurance policy or self-insured health plan for an enrollee the amount that any
16discount provided by the manufacturer of a brand name drug reduces the cost
17sharing amount charged to the enrollee for that brand name drug.
SB70-SSA2-SA4,104 18Section 104. 632.863 of the statutes is created to read:
SB70-SSA2-SA4,94,19 19632.863 Pharmaceutical representatives. (1) Definitions. In this section:
SB70-SSA2-SA4,94,2220 (a) “Health care professional” means a physician or other health care
21practitioner who is licensed to provide health care services or to prescribe
22pharmaceutical or biologic products.
SB70-SSA2-SA4,94,2423 (b) “Pharmaceutical” means a medication that may legally be dispensed only
24with a valid prescription from a health care professional.
SB70-SSA2-SA4,95,3
1(c) “Pharmaceutical representative” means an individual who markets or
2promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical
3manufacturer for compensation.
SB70-SSA2-SA4,95,10 4(2) Licensure. Beginning on the first day of the 12th month beginning after
5the effective date of this subsection .... [LRB inserts date], no individual may act as
6a pharmaceutical representative in this state without being licensed by the
7commissioner as a pharmaceutical representative under this section. In order to
8obtain a license, the individual shall apply to the commissioner in the form and
9manner prescribed by the commissioner. The term of a license issued under this
10subsection is one year and is renewable.
SB70-SSA2-SA4,95,13 11(3) Display of license. A pharmaceutical representative licensed under sub.
12(2) shall display the pharmaceutical representative's license during each visit with
13a health care professional.
SB70-SSA2-SA4,95,16 14(4) Enforcement. (a) Any individual who violates this section shall be fined
15not less than $1,000 nor more than $3,000 for each offense. Each day of continued
16violation constitutes a separate offense.
SB70-SSA2-SA4,95,2017 (b) The commissioner may suspend or revoke the license of a pharmaceutical
18representative who violates this section. A suspended or revoked license may not be
19reinstated until the pharmaceutical representative remedies all violations related
20to the suspension or revocation and pays all assessed penalties and fees.
SB70-SSA2-SA4,95,23 21(5) Rules. The commissioner shall promulgate rules to implement this section,
22including rules that require pharmaceutical representatives to complete continuing
23educational coursework as a condition of licensure.
SB70-SSA2-SA4,105 24Section 105. 632.864 of the statutes is created to read:
SB70-SSA2-SA4,96,2
1632.864 Pharmacy services administrative organizations. (1)
2Definitions. In this section:
SB70-SSA2-SA4,96,33 (a) “Administrative service” means any of the following:
SB70-SSA2-SA4,96,44 1. Assisting with claims.
SB70-SSA2-SA4,96,55 2. Assisting with audits.
SB70-SSA2-SA4,96,66 3. Providing centralized payment.
SB70-SSA2-SA4,96,77 4. Performing certification in a specialized care program.
SB70-SSA2-SA4,96,88 5. Providing compliance support.
SB70-SSA2-SA4,96,99 6. Setting flat fees for generic drugs.
SB70-SSA2-SA4,96,1010 7. Assisting with store layout.
SB70-SSA2-SA4,96,1111 8. Managing inventory.
SB70-SSA2-SA4,96,1212 9. Providing marketing support.
SB70-SSA2-SA4,96,1313 10. Providing management and analysis of payment and drug dispensing data.
SB70-SSA2-SA4,96,1414 11. Providing resources for retail cash cards.
SB70-SSA2-SA4,96,1715 (b) “Independent pharmacy" means a pharmacy operating in this state that is
16licensed under s. 450.06 or 450.065 and is under common ownership with no more
17than 2 other pharmacies.
SB70-SSA2-SA4,96,1818 (c) “Pharmacy benefit manager” has the meaning given in s. 632.865 (1) (c).
SB70-SSA2-SA4,96,2019 (d) “Pharmacy services administrative organization” means an entity
20operating in this state that does all of the following:
SB70-SSA2-SA4,96,2221 1. Contracts with an independent pharmacy to conduct business on the
22independent pharmacy's behalf with a 3rd-party payer.
SB70-SSA2-SA4,96,2523 2. Provides at least one administrative service to an independent pharmacy
24and negotiates and enters into a contract with a 3rd-party payer or pharmacy benefit
25manager on behalf of the independent pharmacy.
SB70-SSA2-SA4,97,3
1(e) “Third-party payer” means an entity, including a plan sponsor, health
2maintenance organization, or insurer, operating in this state that pays or insures
3health, medical, or prescription drug expenses on behalf of beneficiaries.
SB70-SSA2-SA4,97,10 4(2) Licensure. (a) Beginning on the first day of the 12th month beginning after
5the effective date of this paragraph .... [LRB inserts date], no person may operate as
6a pharmacy services administrative organization in this state without being licensed
7by the commissioner as a pharmacy services administrative organization under this
8section. In order to obtain a license, the person shall apply to the commissioner in
9the form and manner prescribed by the commissioner. The application shall include
10all of the following:
SB70-SSA2-SA4,97,1211 1. The name, address, telephone number, and federal employer identification
12number of the applicant.
SB70-SSA2-SA4,97,1413 2. The name, business address, and telephone number of a contact person for
14the applicant.
SB70-SSA2-SA4,97,1515 3. The fee under s. 601.31 (1) (nw).
SB70-SSA2-SA4,97,1616 4. Evidence of financial responsibility of at least $1,000,000.
SB70-SSA2-SA4,97,1717 5. Any other information required by the commissioner.
SB70-SSA2-SA4,97,1918 (b) The term of a license issued under par. (a) shall be 2 years from the date of
19issuance.
SB70-SSA2-SA4,97,23 20(3) Disclosure to the commissioner. (a) A pharmacy services administrative
21organization licensed under sub. (2) shall disclose to the commissioner the extent of
22any ownership or control of the pharmacy services administrative organization by
23an entity that does any of the following:
SB70-SSA2-SA4,97,2424 1. Provides pharmacy services.
SB70-SSA2-SA4,97,2525 2. Provides prescription drug or device services.
SB70-SSA2-SA4,98,2
13. Manufactures, sells, or distributes prescription drugs, biologicals, or medical
2devices.
SB70-SSA2-SA4,98,53 (b) A pharmacy services administrative organization licensed under sub. (2)
4shall notify the commissioner in writing within 5 days of any material change in its
5ownership or control relating to an entity described in par. (a).
SB70-SSA2-SA4,98,6 6(4) Rules. The commissioner may promulgate rules to implement this section.
SB70-SSA2-SA4,106 7Section 106. 632.868 of the statutes is created to read:
SB70-SSA2-SA4,98,8 8632.868 Insulin safety net programs. (1) Definitions. In this section:
SB70-SSA2-SA4,98,109 (a) “Manufacturer" means a person engaged in the manufacturing of insulin
10that is self-administered on an outpatient basis.
SB70-SSA2-SA4,98,1111 (b) “Navigator" has the meaning given in s. 628.90 (3).
SB70-SSA2-SA4,98,1312 (c) “Patient assistance program” means a program established by a
13manufacturer under sub. (3) (a).
SB70-SSA2-SA4,98,1414 (d) “Pharmacy" means an entity licensed under s. 450.06 or 450.065.
SB70-SSA2-SA4,98,1715 (e) “Urgent need of insulin" means having less than a 7-day supply of insulin
16readily available for use and needing insulin in order to avoid the likelihood of
17suffering a significant health consequence.
SB70-SSA2-SA4,98,1918 (f) “Urgent need safety net program” means a program established by a
19manufacturer under sub. (2) (a).
Loading...
Loading...